Schedule 13G ownership disclosure

INFINITY PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 45665G303

Event date: 2017-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
597,030
Percent of class
1.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-18-000132
Form type
SC 13G/A
Filer
INFINITY PHARMACEUTICALS, INC.
CIK
CIK 1113148
Filed
Feb 08, 2018
Reporting period
Dec 29, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub